Franklin Resources Inc. Decreases Stock Holdings in Solventum Co. (NYSE:SOLV)

Franklin Resources Inc. trimmed its holdings in Solventum Co. (NYSE:SOLV) by 34.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 105,430 shares of the company’s stock after selling 55,590 shares during the quarter. Franklin Resources Inc.’s holdings in Solventum were worth $6,965,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Modus Advisors LLC purchased a new position in Solventum in the 4th quarter worth approximately $25,000. Stonebridge Financial Group LLC purchased a new position in Solventum in the 4th quarter worth approximately $26,000. Crews Bank & Trust purchased a new position in Solventum in the 4th quarter worth approximately $32,000. Synergy Asset Management LLC purchased a new position in Solventum in the 4th quarter worth approximately $35,000. Finally, Spire Wealth Management acquired a new stake in shares of Solventum during the 4th quarter worth approximately $37,000.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SOLV. Piper Sandler raised their price target on shares of Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a report on Friday, February 28th. The Goldman Sachs Group raised their price target on shares of Solventum from $63.00 to $71.00 and gave the stock a “sell” rating in a report on Monday, March 3rd. Morgan Stanley raised their price target on shares of Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th. Wells Fargo & Company raised their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. Finally, Bank of America raised their price target on shares of Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a report on Wednesday, February 26th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $79.86.

Solventum Stock Up 8.9 %

Solventum stock opened at $68.61 on Thursday. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $85.92. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The firm has a 50 day moving average price of $74.52 and a 200 day moving average price of $71.75. The company has a market capitalization of $11.87 billion and a PE ratio of 24.95.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.